In the BioHarmony Drug Report Database

"Preview" Icon

Phenprocoumon

Liquamar (phenprocoumon) is a small molecule pharmaceutical. Phenprocoumon was first approved as Liquamar on 1982-01-01. It is used to treat pulmonary embolism, thromboembolism, and venous thrombosis in the USA. The pharmaceutical is active against vitamin K epoxide reductase complex subunit 1.

 

Trade Name

 

Liquamar
 

Common Name

 

phenprocoumon
 

ChEMBL ID

 

CHEMBL1465
 

Indication

 

pulmonary embolism, thromboembolism, venous thrombosis
 

Drug Class

 

Image (chem structure or protein)

Phenprocoumon structure rendering